A type of ‘supercharged’ immune cell could be mass-produced to help fight cancer. The researchers behind the early-stage finding, from Imperial College London, say the development could mark the next generation of cutting-edge immunotherapy treatments, called CAR-T therapies. These personalised treatments involve reprogramming immune cells to kill cancer. NHS England announced on Friday it would […]